Purdue Pharma Cuts More Than Half of U.S. Sales Staff Amid Opioid Crisis Post author:Sam Post published:February 12, 2018 Post category:BioPharma That announcement is a big change in the way Purdue has aggressively marketed OxyContin in the past. Source: BioSpace You Might Also Like BioTelemetry Reaches Key Milestone In Tender Offer For LifeWatch Corp June 8, 2017 Medovex Corporation Retains CG Capital As Investor Relations Counsel April 13, 2017 Teva's Job Cuts Hit 208 Philadelphia Employees January 18, 2018